Stepping up ELIspot: Multi-level analysis in fluorospot assay

Cells

Volumn 3, Issue 4, 2014, Pages 1102-1115

  Janetzki, Sylvia ^a   Rueger, Markus ^b   Dillenbeck, Tomas ^c  

^a DAICEL U S A Inc   (United States)

^b Autoimmun Diagnostika GmbH   (Germany)

^c Mabtech AB   (Sweden)

Author keywords

ELISpot; Fluorochromes; Fluorophores; FluoroSpot; Image analysis; Immunomonitoring

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; FLUOROCHROME; GAMMA INTERFERON; INTERLEUKIN 2;

ARTICLE; CANDIDA ALBICANS; CELL COUNTING; CELL VIABILITY; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FLUOROCHROME STAINING; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGING SYSTEM; MICROPLATE READER; MULTILEVEL ANALYSIS; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SENSITIVITY AND SPECIFICITY; SINGLE CELL ANALYSIS; X RAY SYSTEM;

EID: 84933053127     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3041102     Document Type: Article

References (30)

1. Czerkinsky, C.C.; Nilsson, L.A.; Nygren, H.; Ouchterlony, O.; Tarkowski, A. A solid-phase enzyme-linked immunospot (Elispot) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 1983, 65, 109–121.
2. Cox, J.H.; Ferrari, G.; Janetzki, S. Measurement of cytokine release at the single cell level using the Elispot assay. Methods2006, 38, 274–282.
3. Hoos, A.; Eggermont, A.M.; Janetzki, S.; Hodi, F.S.; Ibrahim, R.; Anderson, A.; Humphrey, R.; Blumenstein, B.; Old, L.; Wolchok, J. Improved endpoints for cancer immunotherapy trials. J. Natl. Cancer Inst. 2010, 102, 1388–1397.
4. Meier, T.; Eulenbruch, H.P.; Wrighton-Smith, P.; Enders, G.; Regnath, T. Sensitivity of a new commercial enzyme-linked immunospot assay (T spot-Tb) for diagnosis of tuberculosis in clinical practice. Eur. J. Clin. Microbiol. Infect. Dis. 2005, 24, 529–536.
5. Cox, J.H.; Ferrari, G.; Kalams, S.A.; Lopaczynski, W.; Oden, N.; D’Souza, M.P. Results of an Elispot proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials. AIDS Res. Hum. Retroviruses2005, 21, 68–81.
6. Janetzki, S.; Panageas, K.S.; Ben-Porat, L.; Boyer, J.; Britten, C.M.; Clay, T.M.; Kalos, M.; Maecker, H.T.; Romero, P.; Yuan J.; et al. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol. Immunother. 2008, 57, 303–315.
7. Britten, C.M.; Gouttefangeas C.; Welters, M.J.; Pawelec, G.; Koch, S.; Ottensmeier, C.; Mander, A.; Walter, S.; Paschen, A.; Muller-Berghaus J.; et al. The CIMT-monitoring panel: A two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays. Cancer Immunol. Immunother. 2008, 57, 289–302.
8. Boaz, M.J.; Hayes, P.; Tarragona, T.; Seamons, L.; Cooper, A.; Birungi, J.; Kitandwe, P.; Semaganda, A.; Kaleebu, P.; Stevens G.; et al. Concordant proficiency in measurement of T-cell immunity in human immunodeficiency virus vaccine clinical trials by peripheral blood mononuclear cell and enzyme-linked immunospot assays in laboratories from three continents. Clin. Vaccine Immunol. 2009, 16, 147–155.
9. Janetzki, S.; Price, L.; Britten, C.M.; van der Burg, S.H.; Caterini, J.; Currier, J.R.; Ferrari, G.; Gouttefangeas C.; Hayes, P.; Kaempgen E.; et al. Performance of serum-supplemented and serum-free media in IFN-gamma Elispot assays for human T cells. Cancer Immunol. Immunother. 2010, 59, 609–618.
10. Filbert, H.; Attig, S.; Bidmon, N.; Renard, B.Y.; Janetzki, S.; Sahin, U.; Welters, M.J.; Ottensmeier, C.; van der Burg, S.H.; Gouttefangeas C.; et al. Serum-free freezing media support high cell quality and excellent Elispot assay performance across a wide variety of different assay protocols. Cancer Immunol. Immunother. 2013, 62, 615–627.
11. Sanchez, A.M.; Rountree, W.; Berrong, M.; Garcia, A.; Schuetz, A.; Cox, J.; Frahm, N.; Manak, M.; Sarzotti-Kelsoe, M.; D'Souza, M.P.; et al. The external quality assurance oversight laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-gamma Elispot) assay. J. Immunol. Method. 2014, 409C, 31–43.
12. Janetzki, S.; Britten, C.M. The impact of harmonization on Elispot assay performance. Method. Mol. Biol. 2012, 792, 25–36.
13. Immudex. Proficiency panel testing. Available online:http://www.proficiencypanel.com(accessed on 2 September 2014).
14. Braesch-Andersen, S.; Paulie, S.; Smedman, C.; Mia, S.; Kumagai-Braesch, M. ApoE production in human monocytes and its regulation by inflammatory cytokines. PLoS One2013, 8, doi:10.1371/journal.pone.0079908.
15. Smedman, C.; Gardlund, B.; Nihlmark, K.; Gille-Johnson, P.; Andersson, J.; Paulie, S. Elispot analysis of LPS-stimulated leukocytes: Human granulocytes selectively secrete IL-8, MIP-1beta and TNF-alpha. J. Immunol. Method. 2009, 346, 1–8.
16. Okamoto, Y.; Abe, T.; Niwa, T.; Mizuhashi, S.; Nishida, M. Development of a dual color enzyme-linked immunospot assay for simultaneous detection of murine T helper type 1- and T helper type 2-cells. Immunopharmacology1998, 39, 107–116.
17. Boulet, S.; Ndongala, M.L.; Peretz, Y.; Boisvert, M.P.; Boulassel, M.R.; Tremblay, C.; Routy, J.P.; Sekaly, R.P.; Bernard, N.F. A dual color Elispot method for the simultaneous detection of IL-2 and IFN-gamma HIV-specific immune responses. J.Immunol. Method. 2007, 320, 18–29.
18. Gazagne, A.; Claret, E.; Wijdenes, J.; Yssel, H.; Bousquet, F.; Levy, E.; Vielh, P.; Scotte, F.; Goupil, T.L.; Fridman, W.H.; et al. A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines. J.Immunol. Method. 2003, 283, 91–98.
19. Gazagne, A.; Malkusch, W.; Vingert, B.; Fridman, W.H.; Tartour, E. Fluorospot assay: Methodological analysis. Method. Mol. Biol. 2005, 302, 289–296.
20. Britten, C.M.; Janetzki, S.; Butterfield, L.H.; Ferrari, G.; Gouttefangeas C.; Huber, C.; Kalos, M.; Levitsky, H.I.; Maecker, H.T.; Melief C.J.; et al. T cell assays and MIATA: The essential minimum for maximum impact. Immunity 2012, 37, 1–2.
21. Rebhahn, J.A.; Bishop, C.; Divekar, A.A.; Jiminez-Garcia, K.; Kobie, J.J.; Lee, F.E.; Maupin, G.M.; Snyder-Cappione, J.E.; Zaiss, D.M.; Mosmann, T.R. Automated analysis of two- and three-color fluorescent Elispot (Fluorospot) assays for cytokine secretion. Comp. Method. Prog. Biomed. 2008, 92, 54–65.
22. Biolegend. Spectraanalyzer. Available online: http://www.biolegend.com/spectraanalyzer (accessed on 24 November 2014).
23. Casey, R.; Blumenkrantz, D.; Millington, K.; Montamat-Sicotte, D.; Kon, O.M.; Wickremasinghe, M.; Bremang, S.; Magtoto, M.; Sridhar, S.; Connell D.; et al.Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS One2010, 5, doi:10.1371/journal.pone.0015619.
24. Sunshine, J.; Kim, M.; Carlson, J.M.; Heckerman, D.; Czartoski, J.; Migueles, S.A.; Maenza, J.; McElrath, M.J.; Mullins, J.I.; Frahm, N. Increased sequence coverage through combined targeting of variant and conserved epitopes correlates with control of HIV replication. J. Virol. 2014, 88, 1354–1365.
25. Han, W.G.; van Twillert, I.; Poelen, M.C.; Helm, K.; van de Kassteele, J.; Verheij, T.J.; Versteegh, F.G.; Boog, C.J.; van Els, C.A. Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. Pertussis with age. PLoS One 2013, 8, doi:10.1371/journal.pone.0083583.
26. Hallengard, D.; Haller, B.K.; Maltais, A.K.; Gelius, E.; Nihlmark, K.; Wahren, B.; Brave, A. Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporation. Clin. Vaccine Immunol. 2011, 18, 1577–1581.
27. Ohrmalm, L.; Smedman, C.; Wong, M.; Broliden, K.; Tolfvenstam, T.; Norbeck, O. Decreased functional T lymphocyte-mediated cytokine responses in patients with chemotherapy-induced neutropenia. J. Intern. Med. 2013, 274, 363–370.
28. Smedman, C.; Ernemar, T.; Gudmundsdotter, L.; Gille-Johnson, P.; Somell, A.; Nihlmark, K.; Gardlund, B.; Andersson, J.; Paulie, S. Fluorospot analysis of TLR-activated monocytes reveals several distinct cytokine secreting subpopulations. Scand. J. Immunol. 2011.
29. Weiss, A.J. Overview of membranes and membrane plates used in research and diagnostic Elispot assays. Method.Mol. Biol. 2012, 792, 243–256.
30. Ahlborg, N.; Axelsson, B. Dual- and triple-color Fluorospot. Method. Mol. Biol. 2012, 792, 77–85.